Document is current
Any future updates will be listed below
-
Authors
Park, Sang-Youl
Qiu, Jingde https://orcid.org/0009-0001-4584-1482
Wei, Shuang
Peterson, Francis C.
Beltrán, Jesús https://orcid.org/0000-0001-8804-3125
Medina-Cucurella, Angélica V.
Vaidya, Aditya S.
Xing, Zenan
Volkman, Brian F. https://orcid.org/0000-0002-6681-5179
Nusinow, Dmitri A. https://orcid.org/0000-0002-0497-1723
Whitehead, Timothy A.
Wheeldon, Ian https://orcid.org/0000-0002-3492-7539
Cutler, Sean R. https://orcid.org/0000-0002-8593-0885
-
Funding
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (HR001118C0137, HR001118C0137, HR001118C0137, HR001118C0137, HR001118C0137, HR001118C0137)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (1R21DA053496-01)
National Science Foundation (NSF-2128246, NSF- 2128287, NSF-2128016)
- License Information
-
More Information
Article History
Received: 27 October 2022
Accepted: 13 September 2023
First Online: 23 October 2023
Competing interests
: S.-Y.P. and S.R.C. are co-inventors on a University of California (UC)-owned patent (US20190389914A1), and S.R.C, I.W., T.A.W., S.W. and J.B. are co-inventors on a joint UC–University of Colorado Boulder (CUB) provisional patent, both of which cover some parts of the research described in the present work. The other authors declare no competing interests.
